|Daily Range||$7.96 - $8.09|
|52-Week Range||$1.55 - $9.98|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||2,252,481|
|Current FY EPS||-$0.35|
How do you think KERX
will perform against the market?
Top KERX Bull/Bear Pitches
zzlangerhans (< 20)
Submitted September 6, 2011
Keryx is another biotech which has struggled recently despite an absence of negative developments specific to the company. The company has already reported positive phase III efficacy data for kidney … More
supez2004 (< 20)
Submitted March 3, 2008
Phase 3 for sulodexide unlikely to impress ...
Keryx Biopharmaceuticals (KERX) Description
A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Website: http://www.keryx.com/